FDA Drug Recalls

Recalls / Active ingredient / Metoprolol Tartrate

Metoprolol Tartrate

7 FDA drug recalls involving the active ingredient “Metoprolol Tartrate”.

DateClassProductFirm
2025-08-06Class IIMetoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2)Westminster Pharmaceuticals LLC
2025-08-06Class IIMetoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2Westminster Pharmaceuticals LLC
2024-05-06Class IIMetoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 3Rubicon Research Private Limited
2021-12-31Class IIMetoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FRubicon Research Private Limited
2021-09-09Class IIMetoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc.Aurobindo Pharma USA Inc.
2021-03-15Class IIMetoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 ManuCardinal Health Inc.
2018-10-15Class IIIMetoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, ManBaxter Healthcare Corporation